← Eichor
Condition: Locally Advanced Cervical Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Locally Advanced Cervical Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Carbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-Neck Cancer
NA · 2 location(s) · University Hospital Heidelberg · NCT04185974Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma
Phase 2 · 7 location(s) · Eye & ENT Hospital of Fudan University · NCT07248956A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer,
Phase 2 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06475300A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and N
Phase 3 · 277 location(s) · GlaxoSmithKline · NCT06256588A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Meth
Phase N/A · 1 location(s) · Centro di Riferimento Oncologico - Aviano · NCT06028724Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT05269381DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07162506Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance C
Phase 3 · 301 location(s) · National Cancer Institute (NCI) · NCT07061977Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
NA · 1 location(s) · Anhui Provincial Hospital · NCT06602843Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC
Phase 2 · 1 location(s) · Beijing Tongren Hospital · NCT06100497BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or S
Phase 2 · 225 location(s) · National Cancer Institute (NCI) · NCT05136196Palliative Radiation for Advanced Cervical Cancer
NA · 1 location(s) · Tata Memorial Hospital · NCT03997110A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or
Phase 1/Phase 2 · 1 location(s) · AP Biosciences Inc. · NCT05473156Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients
Phase 2 · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT05069857Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1
Phase 3 · 1 location(s) · Henan Cancer Hospital · NCT04138212Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer
Phase 3 · 7 location(s) · Zhejiang Cancer Hospital · NCT04974346Window of Opportunity in Preserving Laryngeal Function Trial
Phase 2 · 1 location(s) · Matthew Spector · NCT07423078Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer
Phase 2 · 1 location(s) · Yu Wang · NCT06787911Thermoradiotherapy for Locally Advanced Head and Neck Cancer Patients
Phase 1 · 1 location(s) · Erasmus Medical Center · NCT06761937Immunotherapy Combined With Carbon Ion Radiotherapy for Locally Advanced Cervical Cancer
NA · 1 location(s) · Zhejiang Cancer Hospital · NCT07702838A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadonilimab as
Phase 2 · 1 location(s) · Sun Jing · NCT06356688Toripalimab Combined With Definitive CCRT for LACC Patients
NA · 1 location(s) · Ruijin Hospital · NCT06256224Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and
NA · 4 location(s) · Centre Jean Perrin · NCT05710679Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
Phase 1/Phase 2 · 1 location(s) · Shanghai Chest Hospital · NCT06173986A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid M
Phase 1 · 2 location(s) · Zelluna Immunotherapy AS · NCT07613723CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
Phase 2 · 1 location(s) · Yale University · NCT07172256Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer
Phase 2 · 1 location(s) · Sichuan University · NCT06403878RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer
Phase N/A · 1 location(s) · Fudan University · NCT06530316Neoadjuvant Therapy in Cervical Cancer
NA · 1 location(s) · Qilu Hospital of Shandong University · NCT06558682Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CR
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06509568
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.